MEIP
Price
$2.13
Change
-$0.02 (-0.93%)
Updated
Apr 3 closing price
Capitalization
14.19M
OKYO
Price
$1.23
Change
-$0.02 (-1.60%)
Updated
Apr 3 closing price
Capitalization
42.42M
123 days until earnings call
Ad is loading...

MEIP vs OKYO

Header iconMEIP vs OKYO Comparison
Open Charts MEIP vs OKYOBanner chart's image
MEI Pharma
Price$2.13
Change-$0.02 (-0.93%)
Volume$2.21K
Capitalization14.19M
OKYO Pharma
Price$1.23
Change-$0.02 (-1.60%)
Volume$12.07K
Capitalization42.42M
MEIP vs OKYO Comparison Chart
Loading...
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEIP vs. OKYO commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEIP is a StrongBuy and OKYO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (MEIP: $2.13 vs. OKYO: $1.23)
Brand notoriety: MEIP and OKYO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MEIP: 28% vs. OKYO: 6%
Market capitalization -- MEIP: $14.19M vs. OKYO: $42.42M
MEIP [@Biotechnology] is valued at $14.19M. OKYO’s [@Biotechnology] market capitalization is $42.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEIP’s FA Score shows that 0 FA rating(s) are green whileOKYO’s FA Score has 0 green FA rating(s).

  • MEIP’s FA Score: 0 green, 5 red.
  • OKYO’s FA Score: 0 green, 5 red.
According to our system of comparison, MEIP is a better buy in the long-term than OKYO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEIP’s TA Score shows that 4 TA indicator(s) are bullish while OKYO’s TA Score has 5 bullish TA indicator(s).

  • MEIP’s TA Score: 4 bullish, 4 bearish.
  • OKYO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OKYO is a better buy in the short-term than MEIP.

Price Growth

MEIP (@Biotechnology) experienced а -8.97% price change this week, while OKYO (@Biotechnology) price change was -14.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

MEIP is expected to report earnings on Aug 31, 2023.

OKYO is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OKYO($42.4M) has a higher market cap than MEIP($14.2M). OKYO YTD gains are higher at: 6.644 vs. MEIP (-13.415).
MEIPOKYOMEIP / OKYO
Capitalization14.2M42.4M33%
EBITDA-29.13MN/A-
Gain YTD-13.4156.644-202%
P/E Ratio1.09N/A-
Revenue0N/A-
Total Cash23.7MN/A-
Total Debt11.7MN/A-
FUNDAMENTALS RATINGS
MEIP: Fundamental Ratings
MEIP
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
36
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MEIPOKYO
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
66%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
54%
Advances
ODDS (%)
Bullish Trend 8 days ago
72%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MKL1827.46-51.48
-2.74%
Markel Group
NXGL2.67-0.18
-6.32%
NexGel
REKR0.78-0.06
-6.60%
Rekor Systems
SHAK84.21-11.50
-12.02%
Shake Shack
AMTB18.35-2.54
-12.16%
Amerant Bancorp

MEIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEIP has been loosely correlated with GOSS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MEIP jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEIP
1D Price
Change %
MEIP100%
-0.93%
GOSS - MEIP
45%
Loosely correlated
-3.79%
FBIO - MEIP
28%
Poorly correlated
-5.59%
AXON - MEIP
28%
Poorly correlated
-3.35%
DNLI - MEIP
26%
Poorly correlated
-6.91%
GLUE - MEIP
25%
Poorly correlated
-11.79%
More

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and IGMS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and IGMS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
-1.90%
IGMS - OKYO
26%
Poorly correlated
-5.69%
INZY - OKYO
24%
Poorly correlated
-5.49%
SANA - OKYO
24%
Poorly correlated
-15.95%
MEIP - OKYO
24%
Poorly correlated
-0.93%
CLNN - OKYO
24%
Poorly correlated
+1.67%
More